FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a medicinal substance having anti-stroke action. Use of lithium dihydrate ascorbate as an agent with anti-insult action.
EFFECT: proposed remedy has an anti-stroke effect and helps to reduce the volume of the affected area of the brain during strokes.
1 cl, 2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION, HAVING ANTI-STROKE ACTION | 2020 |
|
RU2737731C1 |
| AGENT WITH NEUROPROTECTIVE ACTIVITY | 2019 |
|
RU2800955C2 |
| CARDIOPROTECTIVE AGENT | 2020 |
|
RU2743764C1 |
| AGENT POSSESSING CARDIOPROTECTIVE ACTIVITY | 2019 |
|
RU2699039C1 |
| NEUROPROTECTIVE MEANS, HAVING THE PROPERTIES OF ANTIOXIDANT AND NITRIC OXIDE DONATOR | 2016 |
|
RU2680526C1 |
| METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
| AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
| USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
| SUBSTANCE OF NEUROTROPIC- NEUROREGULATING ACTIVITY | 2006 |
|
RU2329804C2 |
| SPECIFIC HEXOKINASE-2 INHIBITORS FOR USE IN ACUTE CENTRAL NERVOUS SYSTEM DAMAGE | 2018 |
|
RU2736499C1 |
